iShares MSCI ACWI ETF

ACWI

Capitalización de mercado USD 32.6 mil M

International ETFs are outperforming the S&P 500 in 2026, led by strong gains across Asian and global markets. Here are five ETFs to watch.

International or non-US investing has been quietly putting up robust numbers for shareholders. Today, we are seeing international, gold and even grains of late start to rally, without much give-back in the S&P 500 or Nasdaq.

I reiterate a buy rating on iShares MSCI ACWI ETF (ACWI) as global equities rally on robust earnings growth and strong technical momentum. ACWI's valuation remains reasonable at 15.5x forward P/E, with long-term EPS growth outpacing levels from 16 months ago. Information Technology now comprises 32% of ACWI, increasing sensitivity to the AI trade and concentration risk among top holdings.

Investors have poured money into exchange-traded funds at a rapid pace in the first half of 2026, demonstrating an unrelenting appetite for stocks associated with the AI theme.

Most investors who want global equity exposure end up holding two or three separate funds: one for the U.S.

For investors who want a single ticker to represent the entire investable world, the iShares MSCI ACWI ETF ( NASDAQ:ACWI ) is one of the most direct answers available.

Traditionally, when folks look to play the equity market, many seek to maintain exposure to the Magnificent 7.  However, that is not the only viable method for finding success through equities.

Political and economic tensions, domestic headlines, currency flows and the Federal Reserve have all combined to reignite the “United States vs. international” investing debate.

iShares MSCI ACWI ETF offers broad global equity exposure, with significant concentration in US mega-cap technology stocks. ACWI serves well as a core portfolio holding or equity placeholder, providing diversified beta growth across developed and emerging markets. While ACWI's performance is solid, the Vanguard Total World Stock Index Fund ETF offers similar exposure at a lower fee.

Amploius Wealth sold 25,217 shares of ACWI for an estimated $3.3 million based on the average share price for the third quarter. The transaction represents about 0.3% of 13F reportable assets under management for the period.